semaglutide alcohol use disorder study and Tirzepatide reduce consumption in individuals with obesity Medscape | Once weekly semaglutide

Both published network meta-analyses point in the same direction

Connect with a targeted audience dedicated to mastering multi-agonist design, improving tolerability, clinical trial design and the strategic expansion into neurological and cardiovascular indications

"GLP-1 Benefit Coverage for Employers." June 17, 2025

At Lone Star Centers, Brenda Johnson focuses on helping patients understand how Ozempic fits into their larger health goals from cardiovascular health to sustainable weight management

This creates a persistent "fiber gap" and an opportunity for brands to formulate products that will help consumers close it

Zheng L, et al